- 12:00-13:00
- Session 1Risk Factors, Surveillance, and Prevention(12:00-13:00)
- 13:10-14:10
- Session 2Diagnosis and Staging for HCC and CC(13:10-14:10)
- 14:20-15:35
- Session 3Liver-Directed Therapy(14:20-15:35)
- 15:50-16:50
- Session 4System Treatment for HCC and CC(15:50-16:50)
- 16:50-17:00
- Closing Remarks
- 17:00-17:30
- Session 5APPLE Academy Satellite Symposium(17:00-17:30)
- 08:30-10:00
- Session 1Epidemiology and Surveillance of HCC(08:30-10:00)
-
- 10:10-10:20
- Opening Ceremony
-
- 10:20-10:50
- Presidential Lecture(10:20-10:50)
-
- 11:00-12:30
- Session 2Surgery and Liver Transplantation of HCC(11:00-12:30)
- Session 3Antiviral Therapy and HCC(11:00-12:30)
- 12:30-13:10
- Satellite Symposium - Eisai(12:30-13:10)
- Satellite Symposium - J&J and Hengrui(12:30-13:10)
- 13:10-14:40
- Session 4Locoregional Therapy for HCC: New Roles in Immunotherapy Era(13:10-14:40)
- Session 5Molecular Pathogenesis and Pathology of HCC(13:10-14:30)
- 14:50-16:10
- Session 6Systemic Therapy for Earlier-Stages of HCC (14:50-15:45)
- Session 7Imaging Diagnosis of HCC(14:50-16:10)
- 15:55-16:35
- State-of-the-Art Lecture 1(15:55-16:35)
-
- 16:40-17:20
- APPLE General Assembly(16:40-17:20)
-
- 17:20-18:00
- Satellite Symposium - Roche(17:20-18:00)
-
- 08:00-09:00
- Satellite Symposium - Eisai(08:00-09:00)
-
- 09:00-10:30
- Session 8Multidisciplinary Approach in Vascular Invasive HCC(09:00-10:30)
- Session 9Cholangiocarcinoma(09:00-10:10)
- 10:40-12:00
- Session 10Systemic Therapy for Advanced HCC(10:40-12:10)
- Session 11Abstract Oral Presentation(10:40-12:00)
- 12:10-12:50
- State-of-the-Art Lecture 2(12:10-12:50)
-
- 12:50-13:00
- Wrup-up and Closing(12:50-13:00)
-